GUJTHEMBSEGUJARAT THEMIS BIOSYN LTD· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 28 Aug, 2026 · 20:41 IST

QIP closes at Rs 354/share; company raises about Rs 75 crore

Qip At DiscountFund Raising View source PDFExplain this filing

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.6%Reaction day
₹409.95
prior close
₹415.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+2.3% vs market
Pharmaceuticals peers, median of 174sector-0.3%+2.9% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.4
10m
+3.6
15m
+3.6
30m
+3.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.6+0.3+2.3-0.3+2.9
Next day
+2.4-0.7+3.1-0.7+3.1
2d
+0.9-1.2+2.1-0.5+1.3
3d
+3.6-0.7+4.3-0.2+3.9
4d
+0.4+0.0+0.4-0.1+0.5
5d
+4.7+0.4+4.2+0.0+4.7
1w
+5.4+0.8+4.6+0.0+5.4
15d
+0.7-0.0+0.8+0.0+0.7
1m
-5.7-0.8-4.9+0.0-5.7
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Themis Biosyn closed its Qualified Institutional Placement on Aug 28, 2026, allotting about 2.11 crore equity shares at Rs 354 each, a 4.98% discount to the floor price of Rs 372.57. Total funds raised work out to roughly Rs 75 crore. The shares have a face value of Rs 1 and were placed with eligible QIBs.

Likely market impact

Equity dilution of about 2.11 crore shares for existing holders; QIP priced at a discount to floor may cause short-term price pressure.